Cotton Verticillium wilt resistance-related gene GhCBL3 and its encoding protein and application

By regulating the expression and activity of GhCBL3 protein in cotton, the problem of insufficient resistance to verticillium wort in cotton was solved, significantly improved the disease resistance of cotton, and provided an effective genetic engineering method to enhance its resistance to verticillium wort. force.

CN115820722BActive Publication Date: 2024-11-12NUCLEAR BIOTECHNOLOGY RES INST OF XINJIANG ACAD OF AGRI SCI (XINJIANG UYGUR AUTONOMOUS REGION BIOTECHNOLOGY RES CENT)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210897827.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-07-28
Publication Date
2024-11-12
Estimated Expiration
2042-07-28

AI Technical Summary

Technical Problem

Cotton Verticillium Worm causes significant damage to cotton production, the existing technology is difficult to effectively control, there is a lack of high-resistant cotton varieties, and insufficient research on the resistance mechanism of cotton Verticillium Worm.

Method used

By identifying and utilizing the Ca2+ receptor protein GhCBL3, which is unique in cotton, to regulate its expression and activity to improve or reduce plant disease resistance. Specific methods include gene knockout, gene editing and virus-induced gene silencing technology to construct transgenic cotton to enhance its resistance to verticillium wilt.

Benefits of technology

It significantly improves the anti-verinary wilt properties of cotton, reduces the sensitivity to verinary wilt pathogens by reducing the content and activity of GhCBL3 protein, and delays the progress of the disease, proving the importance of GhCBL3 in cotton's anti-pathologic mechanism.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0003769675330000011
    Figure HDA0003769675330000011
  • Figure HDA0003769675330000012
    Figure HDA0003769675330000012
  • Figure HDA0003769675330000021
    Figure HDA0003769675330000021
Patent Text Reader

Abstract

The present invention discloses a cotton Verticillium wilt resistance-related gene GhCBL3 and its encoding protein and application. The protein is any one of the following: B1) a protein whose amino acid sequence is SEQ ID No.1; B2) a protein having more than 80% identity and the same function as the protein shown in B1) obtained by replacing and / or deleting and / or adding amino acid residues of the amino acid sequence shown in SEQ ID No.1; B3) a fusion protein having the same function obtained by connecting a tag at the N-terminus and / or C-terminus of B1) or B2). The present invention conducts disease resistance identification on transgenic cotton after GhCBL3 gene silencing, and the results show that the incidence rate and disease index of transgenic cotton are significantly reduced, and the resistance to Verticillium wilt is significantly enhanced. Therefore, the GhCBL3 protein and its encoding gene of the present invention can regulate the disease resistance of plants, which is of great significance for cultivating transgenic cotton resistant to Verticillium wilt.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a cotton Verticillium wilt resistance-related gene GhCBL3 in the field of plant genetic engineering, a coded protein and an application thereof. Background Art

[0002] Cotton is an important economic crop in the world. Upland cotton (Gossypiumhirsutum L.) in the genus Gossypium is currently the most widely planted main cultivated cotton species due to its good fiber quality, high yield and short growth cycle, accounting for about 95% of the world's total cotton production. Cotton Verticillium wilt is the most important disease in cotton production and is also one of the national agricultural plant quarantine objects. Cotton Verticillium wilt is a devastating vascular disease in cotton production caused by a soil-borne pathogenic fungus Verticillium dahliae, which seriously restricts the growth and development of cotton and has become the world's number one cotton disease, known as the "cancer" of cotton. So far, cotton Verticillium wilt has not been effectively controlled in Upland cotton, and Upland cotton varieties with high resistance to Verticillium wilt are still difficult to obtain. Years of practice have proved that discovering disease-resistant genes, understanding the response mechanism of cotton to Verticillium wilt, accelerating the breeding process of cotton resistance to Verticillium wilt, and then improving cotton's disease resistance have become the main ways to breed cotton resistance to Verticillium wilt.

[0003] With the rapid development of molecular biology, people have gradually deepened their understanding of the molecular mechanisms of plant biological stress response. As a ubiquitous second messenger in plants, Ca 2+ Participates in regulating plant growth and development and multiple stress responses. Studies have shown that stress acts on plant cells, first causing changes in intracellular calcium ion concentration, Ca 2+ The concentration changes in a specific way in time and space, and this change is reflected by the corresponding Ca 2+ The receptors sense the Ca2+, which then transmits the signal to downstream target proteins, thereby initiating a series of physiological and biochemical reactions in the cell to respond to stress. 2+ Receptor proteins are mainly divided into three categories: calmodulin (CaM), calcineurin B-like proteins (CBL) and calcium-dependent protein kinase (CDPK). 2+The receptor protein, calcineurin B-like protein (CBL), can transmit signals through the proteins it interacts with and regulate the expression of downstream early response genes. CBL-type calcium receptors are small molecule proteins that are only found in plants and are extremely similar to animal calcineurin B subunits (CNB) and central nervous calcium receptors (NCS), namely CBL or CBL calcium receptors. The CBL receptor and the protein kinase CIPK that interacts with it constitute the CBL-CIPK signaling system to regulate the response to calcium signals and regulate the expression of downstream genes. In the genomes of the dicotyledonous plant Arabidopsis and the monocotyledonous plants rice and corn, the CBL gene family contains 10 members. These 10 CBL genes all contain 6 or 7 introns in the coding region, of which 4 introns are highly conserved in the position and arrangement order of the coding regions of these 10 genes. At present, research on CBL genes is mostly focused on plant responses to adverse stresses such as drought, salt, alkali, and low temperature, but there have been no reports on their resistance function to cotton Verticillium wilt. CBL protein is mainly composed of two globular domains, N-terminal and C-terminal, each of which contains a pair of EF-hand motifs, each of which consists of 12 amino acid residues. Compared with the amino acid sequence of the typical EF-hand motif of CaM (DXD(N)XD(N)(S)GXI(V)D(N)(S)XXE), the EF-hand structure of CBL has different degrees of variation. For example, among the 10 members of the Arabidopsis CBL family, AtCBL1 and AtCBL9 have two typical EF-hand motifs, AtCBL6, AtCBL7, AtCBL8 and AtCBL10 only contain one typical EF-hand motif, while AtCBL2, AtCBL3, AtCBL4 and AtCBL5 have no typical EF-hand motif. Cotton CBL3 has four EF-hand motifs, which can serve as calcium binding sites.

[0004] In view of this, mining and identifying Verticillium wilt resistance genes, analyzing the genetic basis of Verticillium wilt resistance, and combining biotechnology to design disease-resistant molecular breeding can fundamentally prevent and control the harm of Verticillium wilt in cotton, accelerate the selection and breeding of Verticillium wilt-resistant cotton varieties, promote the process of commercial cotton breeding, and effectively solve the problem of lack of disease-resistant varieties in production. Improving cotton's Verticillium wilt resistance through genetic means is not only the most economical and effective solution, but also has important significance for ensuring the quality and high and stable yield of cotton. It also has a wide range of application value in the field of cotton molecular breeding. Summary of the invention

[0005] The technical problem to be solved by the present invention is how to regulate the disease resistance of plants (such as increasing or decreasing the resistance of plants to Verticillium wilt). The technical problem to be solved is not limited to the described technical subject matter, and those skilled in the art can clearly understand other technical subjects not mentioned herein through the following description.

[0006] In order to solve the above technical problems, the present invention first provides the application of a protein or a substance for regulating the activity and / or content of the protein, and the application may be any of the following:

[0007] A1) Use of proteins or substances that regulate the activity and / or content of the proteins in regulating plant disease resistance;

[0008] A2) Use of a protein or a substance that regulates the activity and / or content of the protein in the preparation of a product that regulates plant disease resistance;

[0009] A3) Use of proteins or substances that regulate the activity and / or content of the proteins in breeding disease-resistant plants;

[0010] A4) Use of a protein or a substance that regulates the activity and / or content of the protein in the preparation of a product for breeding disease-resistant plants;

[0011] A5) Use of proteins or substances that regulate the activity and / or content of the proteins in plant breeding or plant germplasm resource improvement;

[0012] A6) Use of proteins or substances that regulate the activity and / or content of the proteins in preventing and controlling cotton diseases;

[0013] The protein is named GhCBL3, which can be any of the following:

[0014] B1) a protein whose amino acid sequence is SEQ ID No. 1;

[0015] B2) a protein having 10% or more identity with the protein shown in B1) and having the same function as the protein shown in B1) obtained by substitution and / or deletion and / or addition of amino acid residues of the amino acid sequence shown in SEQ ID No.1;

[0016] B3) A fusion protein having the same function obtained by connecting a tag to the N-terminus and / or C-terminus of B1) or B2).

[0017] In the above application, the protein GhCBL3 can be derived from cotton (Gossypium spp.).

[0018] Furthermore, the protein GhCBL3 may be derived from upland cotton (Gossypium hirsutum L.).

[0019] Furthermore, the protein GhCBL3 may be involved in Ca 2+ Regulated cotton calcineurin B-like proteins (CBL) GhCBL3.

[0020] Furthermore, the protein GhCBL3 may be a cotton disease resistance-related protein GhCBL3, and specifically may be a cotton Verticillium wilt resistance-related protein GhCBL3.

[0021] Furthermore, the protein GhCBL3 may be cotton Verticillium wilt resistance-related protein GhCBL3.

[0022] In order to facilitate purification or detection of the protein in B1), a tag protein may be connected to the amino terminus or carboxyl terminus of the protein consisting of the amino acid sequence shown in SEQ ID No. 1 in the sequence listing.

[0023] The tag protein includes but is not limited to: GST (glutathione sulfhydryltransferase) tag protein, His6 tag protein (His-tag), MBP (maltose binding protein) tag protein, Flag tag protein, SUMO tag protein, HA tag protein, Myc tag protein, eGFP (enhanced green fluorescent protein), eCFP (enhanced cyan fluorescent protein), eYFP (enhanced yellow-green fluorescent protein), mCherry (monomeric red fluorescent protein) or AviTag tag protein.

[0024] A person skilled in the art can easily mutate the nucleotide sequence encoding the protein GhCBL3 of the present invention by using known methods, such as directed evolution or point mutation. Those artificially modified nucleotides having 75% or more identity with the nucleotide sequence of the protein GhCBL3 isolated from the present invention are derived from the nucleotide sequence of the present invention and are equivalent to the sequence of the present invention as long as they encode the protein GhCBL3 and have the function of the protein GhCBL3.

[0025] The aforementioned 75% or more identity may be 80%, 85%, 90% or 95% or more identity.

[0026] Herein, identity refers to the identity of an amino acid sequence or a nucleotide sequence. The identity of an amino acid sequence can be determined using a homology search site on the Internet, such as the BLAST webpage on the NCBI homepage website. For example, in Advanced BLAST2.1, by using blastp as a program, setting the Expect value to 10, setting all Filters to OFF, using BLOSUM62 as a Matrix, setting Gap existence cost, Per residue gap cost and Lambda ratio to 11, 1 and 0.85 (default values) respectively and searching to calculate the identity of an amino acid sequence, the value (%) of identity can then be obtained.

[0027] Herein, the 80% or greater identity may be at least 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identity.

[0028] Herein, the substance that regulates the activity and / or content of the protein may be a substance that regulates the expression of a gene encoding the protein GhCBL3.

[0029] In the above, the substance that regulates gene expression may be a substance that performs at least one of the following six types of regulation: 1) regulation at the transcription level of the gene; 2) regulation after transcription of the gene (that is, regulation of the splicing or processing of the primary transcript of the gene); 3) regulation of RNA transport of the gene (that is, regulation of the transport of the mRNA of the gene from the nucleus to the cytoplasm); 4) regulation of the translation of the gene; 5) regulation of the degradation of the mRNA of the gene; 6) post-translational regulation of the gene (that is, regulation of the activity of the protein translated from the gene).

[0030] The substance that regulates gene expression may specifically be any biological material described in E1) to B4) herein.

[0031] Furthermore, the substance regulating gene expression may be a substance (including a nucleic acid molecule or a vector) that inhibits, reduces or downregulates the expression of the gene encoding the protein GhCBL3.

[0032] Furthermore, the substance regulating gene expression may also be a substance (including a nucleic acid molecule or a vector) that increases or upregulates the expression of the gene encoding the protein GhCBL3.

[0033] The present invention also provides an application of a biomaterial related to the protein GhCBL3, and the application may be any of the following:

[0034] D1) Application of biological materials related to the protein GhCBL3 in regulating plant disease resistance;

[0035] D2) Use of biological materials related to the protein GhCBL3 in the preparation of products for regulating plant disease resistance;

[0036] D3) Use of biological materials related to the protein GhCBL3 in cultivating disease-resistant plants;

[0037] D4) Use of biological materials related to the protein GhCBL3 in preparing products for cultivating disease-resistant plants;

[0038] D5) Application of biological materials related to the protein GhCBL3 in plant breeding or plant germplasm resource improvement;

[0039] D6) Application of biological materials related to the protein GhCBL3 in preventing and controlling cotton diseases;

[0040] The biological material may be any one of the following E1) to E8):

[0041] E1) a nucleic acid molecule encoding the protein GhCBL3;

[0042] E2) a nucleic acid molecule that inhibits or reduces the expression of the gene encoding the protein GhCBL3;

[0043] E3) an expression cassette containing the nucleic acid molecule described in E1) and / or E2);

[0044] E4) a recombinant vector containing the nucleic acid molecule described in E1) and / or E2), or a recombinant vector containing the expression cassette described in E3);

[0045] E5) a recombinant microorganism containing the nucleic acid molecule described in E1) and / or E2), or a recombinant microorganism containing the expression cassette described in E3), or a recombinant microorganism containing the recombinant vector described in E4);

[0046] E6) a transgenic plant cell line containing the nucleic acid molecule described in E1) and / or E2), or a transgenic plant cell line containing the expression cassette described in E3), or a transgenic plant cell line containing the recombinant vector described in B4);

[0047] E7) transgenic plant tissue containing the nucleic acid molecule described in E1) and / or E2), or transgenic plant tissue containing the expression cassette described in E3);

[0048] E8) A transgenic plant organ containing the nucleic acid molecule described in E1) and / or E2), or a transgenic plant organ containing the expression cassette described in E3).

[0049] In the above application, the nucleic acid molecule may be any of the following:

[0050] F1) a DNA molecule whose coding sequence is SEQ ID No. 2 or SEQ ID No. 3;

[0051] F2) A DNA molecule whose nucleotide sequence is SEQ ID No. 2 or SEQ ID No. 3.

[0052] The DNA molecule shown in SEQ ID No.2 (cotton Verticillium wilt resistance-related gene GhCBL3) encodes the protein GhCBL3 whose amino acid sequence is SEQ ID No.1.

[0053] The nucleotide sequence shown in SEQ ID NO.2 is the nucleotide sequence of the protein GhCBL3 encoding gene (CDS).

[0054] E1) The nucleic acid molecule may also include a nucleic acid molecule obtained by modifying the codon preference based on the nucleotide sequence shown in SEQ ID No. 2.

[0055] E1) The nucleic acid molecule also includes a nucleic acid molecule having a nucleotide sequence identity of more than 95% with the nucleotide sequence shown in SEQ ID No. 2 and originating from the same species.

[0056] The gene of the protein GhCBL3 (GhCBL3 gene) of the present invention can be any nucleotide sequence that can encode the protein GhCBL3. Considering the degeneracy of codons and the preference of codons of different species, those skilled in the art can use codons suitable for expression of a specific species as needed.

[0057] The expression cassette comprises a promoter, a nucleic acid molecule encoding the protein GhCBL3 and a terminator. The promoter may be a CaMV35S promoter, a NOS promoter or an OCS promoter. The terminator may be a NOS terminator or an OCS polyA terminator.

[0058] The nucleic acid molecule described herein can be DNA, such as cDNA, genomic DNA or recombinant DNA; the nucleic acid molecule can also be RNA, such as gRNA, mRNA, siRNA, shRNA, sgRNA, miRNA or antisense RNA.

[0059] The vectors described herein are well known to those skilled in the art, including but not limited to: plasmids, phages (such as lambda phage or M13 filamentous phage, etc.), cosmids (i.e., cosmids), Ti plasmids or viral vectors. Specifically, the vectors may be PYL156 and / or -Blunt Zero Cloning Vector.

[0060] The microorganism described herein may be yeast, bacteria, algae or fungi. Among them, the bacteria may be from Escherichia, Erwinia, Agrobacterium, Flavobacterium, Alcaligenes, Pseudomonas, Bacillus, etc. Specifically, it may be Agrobacterium GV3101 and / or Escherichia coli DH5α.

[0061] The recombinant vector may specifically be the recombinant vector pEASY-GhCBL3 and / or the recombinant vector PYL156-GhCBL3.

[0062] The recombinant vector pEASY-GhCBL3 (i.e., pEASY-GhCBL3 plasmid) is cloned by sticky end cloning, wherein the DNA fragment whose nucleotide sequence is SEQ ID No. 3 in the sequence list is connected to -Blunt Zero CloningVector carrier, keep -The other sequences of the Blunt Zero Cloning Vector remain unchanged to obtain a recombinant vector.

[0063] The recombinant vector PYL156-GhCBL3 is obtained by replacing the fragment (small fragment) between the EcoRI and KpnI recognition sites of the PYL156 vector with the DNA fragment shown in SEQ ID No. 3 in the sequence table, while keeping the other nucleotide sequences of the PYL156 vector unchanged.

[0064] The recombinant microorganism can be obtained by introducing the recombinant vector into a starting microorganism.

[0065] The recombinant vector carrying the GhCBL3 gene of the present invention can be used to transform plant cells or tissues by conventional biological methods such as Ti plasmid, Ri plasmid, plant virus vector, direct DNA transformation, microinjection, electroporation, Agrobacterium-mediated transformation, and the transformed plant tissues can be cultivated into plants.

[0066] The recombinant microorganism may specifically be recombinant Agrobacterium GV3101 / PYL156-GhCBL3.

[0067] The recombinant Agrobacterium GV3101 / PYL156-GhCBL3 is a recombinant bacterium obtained by introducing the recombinant vector PYL156-GhCBL3 into Agrobacterium tumefaciens GV3101.

[0068] The present invention also provides a method for cultivating disease-resistant plants, which may include reducing the content and / or activity of the protein GhCBL3 in the target plant to obtain a disease-resistant plant having higher disease resistance than the target plant.

[0069] In the above method, reducing the content and / or activity of the protein GhCBL3 in the target plant can be achieved by reducing the expression level of the gene encoding the protein GhCBL3 in the target plant.

[0070] In the above method, reducing the expression level of the gene encoding the protein GhCBL3 in the target plant can be achieved by using gene mutation, gene knockout, gene editing or gene knockdown technology to reduce the expression level of the gene encoding the protein GhCBL3 in the target plant genome.

[0071] In the above method, the gene knockdown technology used to reduce the expression level of the gene encoding the protein GhCBL3 in the genome of the target plant can be carried out using a virus-induced gene silencing vector, and the virus-induced gene silencing vector is a recombinant vector constructed by forward integration of the nucleic acid molecule shown in SEQ ID No. 3 into a plasmid vector based on tobacco rattle virus (Tobacco rattlevirus, TRV).

[0072] Furthermore, the plasmid vector based on tobacco rattle virus (TRV) may be a PYL156 vector.

[0073] The method for cultivating disease-resistant plants of the present invention may include the following steps: inhibiting the expression of a nucleic acid molecule capable of expressing a GhCBL3 protein in a recipient plant (target plant) to obtain a transgenic plant; the transgenic plant has improved disease resistance compared with the recipient plant. The inhibiting the expression of a nucleic acid molecule capable of expressing a GhCBL3 protein in the recipient plant may be achieved by any technical means capable of achieving this purpose.

[0074] The method for cultivating disease-resistant plants of the present invention may include the following steps:

[0075] M1) inserting the nucleic acid molecule shown in SEQ ID No.3 into a plasmid vector containing a tobacco rattle virus sequence to construct a recombinant plasmid (i.e., a gene silencing vector);

[0076] M2) introducing the recombinant plasmid into target plants (such as crops or cotton);

[0077] M3) The disease-resistant plant is obtained through screening and identification.

[0078] The introduction refers to recombinant means, including but not limited to Agrobacterium-mediated transformation, biolistic methods, electroporation or in planta technology.

[0079] Herein, the plant may be a crop (eg, an agricultural crop).

[0080] In the above application and / or method, the plant may be any of the following:

[0081] G1) monocots or dicots;

[0082] G2) Malvaceae;

[0083] G3) cotton plants;

[0084] G4) Cotton.

[0085] Furthermore, the cotton may specifically be upland cotton (Gossypium hirsutum L.).

[0086] The protein GhCBL3, and / or, the biological material are also within the protection scope of the present invention.

[0087] The present invention also provides application of the method for cultivating disease-resistant plants in creating disease-resistant plants and / or plant breeding and / or improving plant germplasm resources.

[0088] Herein, the disease-resistant plant may be a plant with improved (up-regulated) disease resistance.

[0089] In the present invention, the regulation may be up-regulation, attenuation or reduction. The regulation may also be down-regulation, enhancement or improvement.

[0090] The regulation of plant disease resistance described herein may be increasing (up-regulating) plant disease resistance or decreasing (down-regulating) plant disease resistance.

[0091] Herein, the disease resistance may be Verticillium wilt resistance.

[0092] Specifically, the regulation of plant disease resistance described herein may be regulation of plant resistance to Verticillium wilt, including increasing (up-regulating) the plant's resistance to Verticillium wilt or decreasing (down-regulating) the plant's resistance to Verticillium wilt.

[0093] Any of the above mentioned Verticillium wilt diseases may specifically be Verticillium wilt disease caused by Verticillium dahliae.

[0094] The plant breeding described herein may be crop disease resistance breeding, specifically cotton Verticillium wilt resistance breeding, and the purpose of the breeding is to breed cotton with improved Verticillium wilt resistance.

[0095] The plant breeding described herein may be molecular breeding that utilizes the gene GhCBL3 and / or protein GhCBL3 described in the present invention to improve crop disease resistance.

[0096] The cotton disease described herein may be a disease caused by the fungus Verticillium dahliae, and specifically may be cotton Verticillium wilt disease.

[0097] Herein, the disease-resistant plants are understood to include not only the first-generation transgenic plants obtained by silencing or knocking out the GhCBL3 gene, but also their progeny. The transgenic plants include seeds, callus tissues, complete plants and cells.

[0098] The invention provides a cotton calcineurin B subunit protein CBL3 gene and a protein encoded therein. The gene is amplified by using GhCBL3 gene sequence information, and a VIGS plant expression vector is constructed to transform upland cotton TM-1 to obtain transgenic cotton. Disease resistance of the transgenic cotton is further identified. After inoculation with cotton Verticillium wilt pathogen V991, the incidence rate and disease index of the transgenic cotton are significantly reduced, showing resistance to Verticillium wilt, indicating that the disease resistance of the plant is enhanced after the GhCBL3 gene is silenced, indicating that the GhCBL3 gene is involved in the allergic reaction induced by Verticillium wilt, and the GhCBL3 gene and the protein encoded therein are involved in the cotton Verticillium wilt resistance mechanism.

[0099] In summary, inhibiting (down-regulating) the expression of the GhCBL3 gene in plants (such as cotton) will significantly improve the disease resistance of the plants (such as improving the resistance to Verticillium wilt in cotton). The GhCBL3 protein of the present invention and its encoding gene GhCBL3 can regulate the disease resistance of plants (such as Verticillium wilt resistance), and the disease resistance of the target plants can be significantly improved by reducing the content and / or activity of the GhCBL3 protein in the target plants (such as inhibiting, silencing or interfering with the expression of the GhCBL3 gene). Therefore, the cotton Verticillium wilt resistance-related protein GhCBL3 and its encoding gene have important theoretical significance and practical value in regulating plant disease resistance, and the present invention is of great significance for cultivating Verticillium wilt-resistant transgenic cotton. BRIEF DESCRIPTION OF THE DRAWINGS

[0100] Figure 1 This is the detection and disease resistance identification of the VIGS genetic transformation system in Example 2. Figure 1 Middle A and Figure 1 Middle B (control, TRV: 00) is a phenotypic identification diagram of the successful establishment of the TRV-mediated VIGS system in Upland Cotton TM-1; Figure 1 Middle C is the growth comparison between cotton plants inoculated with Verticillium wilt V991 12 days after VIGS infection for two weeks and the control (TRV: 00);

[0101] Figure 2 The expression level of GhCBL3 gene was detected by fluorescence quantitative Real time-PCR.

[0102] Figure 3 Statistical analysis of the incidence and disease index 16 days and 21 days after inoculation with Verticillium dahliae strain V991. DETAILED DESCRIPTION

[0103] The present invention is further described in detail below in conjunction with specific embodiments, and the examples provided are only for illustrating the present invention, rather than for limiting the scope of the present invention. The examples provided below can be used as a guide for further improvements by those of ordinary skill in the art, and do not constitute a limitation of the present invention in any way.

[0104] The experimental methods in the following examples, unless otherwise specified, are all conventional methods, and are performed according to the techniques or conditions described in the literature in the field or according to the product instructions. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial channels.

[0105] The following examples were processed using Graphpad Prism8 statistical software, and the experimental results were expressed as mean ± standard deviation. T test method was used, P < 0.05 (*) indicated statistical difference, P < 0.01 (**) indicated statistically significant difference, and P < 0.001 (***) indicated extremely statistically significant difference. The quantitative tests in the following examples were repeated three times unless otherwise specified, and the results were averaged.

[0106] The upland cotton genetic standard line TM-1 (abbreviated as upland cotton TM-1) in the following examples was donated to the Cotton Research Institute of the Chinese Academy of Agricultural Sciences and is recorded in the following literature: Fu Yang, Yuan Dongdong, Hu Wenjing, et al. Breeding of chromosome 18 segment replacement lines of sea island cotton under upland cotton background and QTL positioning of related agronomic traits [J]. Acta Agronomica Sinica, 2013, 39(1): 21-28. The public can obtain the biological material from the applicant. The biological material is only used for repeating the experiments of the present invention and cannot be used for other purposes.

[0107] The plant VIGS expression vector PYL156 in the following example was donated by Professor Zou Baohong of Nanjing Agricultural University. It is a TRV-mediated gene silencing vector and is described in the following literature: Yang Xiaomin, Wang Junjuan, Wang Delong, et al. Functional verification and bioinformatics analysis of cotton GhDMT3 [J]. Biotechnology Bulletin, 2019, 35(1): 11-16. The public can obtain the biological material from the applicant. The biological material is only used to repeat the experiment of the present invention and cannot be used for other purposes.

[0108] The Agrobacterium tumefaciens GV3101 in the following examples was purchased from Ke Rui Da Trading Company in Urumqi High-tech Development Zone.

[0109] The Verticillium dahliae V991 in the following example is recorded in the following document: Zhang Xin, Jian Guiliang, Lin Ling, et al. Molecular detection method of deciduous cotton Verticillium wilt in soil [J]. Journal of Jiangsu Agricultural Sciences, 2011, 27(5): 990-995. The public can obtain the biological material from the applicant. The biological material is only used for repeating the experiment of the present invention and cannot be used for other purposes.

[0110] Example 1. Obtaining cotton disease resistance-related protein GhCBL3 and its encoding gene

[0111] After extensive and in-depth research, the inventors of the present application discovered a DNA coding sequence by analyzing the cotton genome sequence, the nucleotide sequence of which is shown in SEQ ID No. 2 of the sequence listing, and the amino acid sequence of the protein encoded by it is shown in SEQ ID No. 1 of the sequence listing.

[0112] The nucleotide sequence shown in SEQ ID No.2 was named GhCBL3 gene, the protein encoded by it was named GhCBL3 protein, and the amino acid sequence was shown in SEQ ID No.1.

[0113] GhCBL3 protein is cotton calcineurin B subunit protein GhCBL3.

[0114] Example 2: Application of cotton disease resistance-related protein GhCBL3 and its encoding gene

[0115] 1. Obtaining the GhCBL3 gene fragment containing restriction sites

[0116] Total RNA of cotton (upland cotton genetic standard line TM-1) was extracted and reverse transcribed into cDNA. Using cDNA as a template, PCR amplification was performed using a primer pair consisting of GhCBL3F / R primers, i.e., primer GhCBL3F and primer GhCBL3R, to obtain a PCR amplification product. The primer sequences are as follows:

[0117] Primer GhCBL3F: 5'-CG GAATTC TAGGTTTCGAAGAGTTTGCTC-3′;

[0118] Primer GhCBL3R: 5'-GG GGTACC TCAGGTATCATCAACTTGAGAGT-3'.

[0119] In primer GhCBL3F and primer GhCBL3R, the underlined sequences are restriction enzymes EcoRI and KpnI, respectively, to facilitate subsequent connection to the plant expression vector PYL156 for cotton genetic transformation.

[0120] The PCR amplification product (393 bp, SEQ ID No. 3) is a GhCBL3 gene fragment containing restriction sites, i.e., restriction sites for EcoRI and KpnI restriction endonucleases are added at 305 bp and 681 bp of the GhCBL3 gene shown in SEQ ID No. 2 (681 bp). The PCR amplification product (393 bp, SEQ ID No. 3) was detected by 1% agarose gel electrophoresis and recovered and purified for later use.

[0121] 2. Construction of virus-induced gene silencing (VIGS) recombinant expression vector PYL156-GhCBL3

[0122] The PCR amplification product (393 bp, SEQ ID No. 3) obtained in step 1 was -Blunt ZeroCloning Vector( -Components in Blunt Zero Cloning Kit, -Blunt ZeroCloning Kit is a product of Quanshijin Biotechnology Co., Ltd., item number CB501-01) and the ligation product was transformed into Escherichia coli DH5α. The positive transformants were identified by PCR using GhCBL3F / R primers and sent for sequencing. The colonies with correct sequencing were preserved, and the plasmids were extracted. The plasmid with correct sequence was named pEASY-GhCBL3. The pEASY-GhCBL3 plasmid contains a DNA fragment with the nucleotide sequence of SEQ ID No.3.

[0123] The recombinant vector pEASY-GhCBL3 (i.e., pEASY-GhCBL3 plasmid) is prepared by using the sticky end cloning method to connect the DNA fragment whose nucleotide sequence is SEQ ID No. 3 in the sequence list to -Blunt Zero CloningVector carrier, keep -The other sequences of the Blunt Zero Cloning Vector remain unchanged to obtain a recombinant vector.

[0124] The plant VIGS expression vector PYL156 (TRV-mediated gene silencing vector) was digested with restriction endonucleases EcoRI and KpnI, and the backbone vector after digestion was recovered.

[0125] The plasmid pEASY-GhCBL3 obtained above was digested with restriction endonucleases EcoRI and KpnI, and the digested DNA fragment 1 (small fragment) was recovered.

[0126] The DNA fragment 1 was connected to the backbone vector after enzyme digestion to obtain the virus-induced gene silencing (VIGS) recombinant expression vector PYL156-GhCBL3.

[0127] The recombinant vector PYL156-GhCBL3 is obtained by replacing the fragment (small fragment) between the EcoRI and KpnI recognition sites of the PYL156 vector with the DNA fragment shown in SEQ ID No. 3 in the sequence table inserted in the forward direction, while keeping the other nucleotide sequences of the PYL156 vector unchanged.

[0128] 3. Obtaining recombinant Agrobacterium

[0129] The plant expression vector recombinant plasmid PYL156-GhCBL3 obtained in step 2 was transformed into Agrobacterium tumefaciens GV3101, and a single clone was picked to perform colony PCR screening and identification of the recombinant plasmid PYL156-GhCBL3 using GhCBL3F / R primers to confirm that an Agrobacterium-positive clone (i.e., a recombinant Agrobacterium into which PYL156-GhCBL3 was transferred) was obtained and named GV3101 / PYL156-GhCBL3.

[0130] 4. Obtaining genetically modified cotton

[0131] 4-1. The obtained recombinant Agrobacterium GV3101 / PYL156-GhCBL3 was streaked and cultured on LB solid medium containing kanamycin (50 ug / ml) and gentamicin (20 ug / ml) resistance, and cultured at 28° C. for 2 days.

[0132] 4-2. Pick the single clone obtained in step 4-1 and inoculate it into 5 ml of LB liquid medium containing kanamycin (50ug / ml) and gentamicin (20ug / ml) resistance, and incubate at 28℃ for 180 min. -1 Culture for 24 hours; transfer to 50 mL LB liquid medium, 28°C, 180 rpm -1 Incubate for 12 h at 4000 rpm -1 The bacterial cells were collected by centrifugation for 5 min and resuspended in an appropriate volume of solution (10 mmol L – 1 MgCl2, 10mmol L –1 2-(N-morpholino)ethanesulfonic acid (MES) and 200 μmol L –1 Acetosyringone) resuspended, adjust OD 600nm The value was adjusted to 1.5; the resuspended solution was allowed to stand at room temperature for more than 3 hours to obtain the recombinant Agrobacterium transformation suspension (i.e., GV3101 / PYL156-GhCBL3 bacterial solution).

[0133] The GhCLA1 gene (GenBank accession number KJ123647) was cloned from the genetic standard line TM-1 of upland cotton. A 994-1414 bp gene fragment located in the middle of the cotton GhCLA1 gene ORF was amplified, and the target amplified fragment length was 421 bp. The amplified CLA1 gene fragment was connected with the PYL156 vector to construct a recombinant vector PYL156-CLA1. The recombinant vector PYL156-CLA1 was transformed into Agrobacterium tumefaciens GV3101 to obtain a GV3101 / PYL156-CLA1 bacterial solution.

[0134] pTRV1 bacterial solution is used in combination with GV3101 / PYL156-GhCBL3 bacterial solution to achieve gene silencing, as described in the following literature: Establishment and application of TRV virus-mediated gene silencing system in cotton, Wang Xinyu, Lü Kun, Cai Caiping, Xu Jun, Guo Wangzhen, et al., [J]. Acta Agronomica Sinica, 2014, 40(8): 1356-1363.

[0135] GV3101 / PYL156-CLA1 bacterial solution was used as the positive control bacterial solution.

[0136] GV3101 / PYL156 bacterial solution is a negative control bacterial solution, that is, the PYL156 vector is transformed into Agrobacterium tumefaciens GV3101 to obtain a PYL-156 empty vector bacterial solution.

[0137] The experiment was set up with three treatments as follows:

[0138] 1. Mix the pTRV1 bacterial solution and the GV3101 / PYL156-GhCBL3 bacterial solution at a volume ratio of 1:1 and inject into cotton cotyledons to obtain gene silencing transformants, which are recorded as TRV:GhCBL3.

[0139] 2. Mix the pTRV1 bacterial solution and the GV3101 / PYL156-CLA1 bacterial solution in a volume ratio of 1:1 and inject into cotton cotyledons to detect whether the gene silencing system is correct, recorded as TRV:GhCLA1.

[0140] 3. Mix the pTRV1 bacterial solution and the GV3101 / PYL156 bacterial solution in a volume ratio of 1:1 and inject into cotton cotyledons as a genetic transformation control strain, recorded as TRV:00.

[0141] 4-3. Sow the seeds of Upland Cotton TM-1 in nutrient soil, and culture them under 12h light / 12h dark conditions at 26-28℃. Keep the humidity at 60% or above, water them once every 4-5 days, and use them for VIGS operation when the two cotyledons are flat and the true leaves have not yet developed.

[0142] 4-4. VIGS injection infection: First, gently puncture the back of the cotyledon with a syringe needle to create a microwound, and inject the 1:1 mixed resuspension from the wound with a syringe without a needle to obtain the cotton GhCBL3 gene silencing transformant. After 2 weeks, observe the phenotype of cotton with different treatments and detect the expression of the target gene. Treat 30 individual plants for each material.

[0143] Reference for the specific method of Agrobacterium VIGS: Gao, X., Shan, L. Functional genomic analysis of cotton genes with agrobacterium-mediated virus-induced genesilencing. Methods Mol Biol, 2013, 975: 157-165.

[0144] 5. Detection of VIGS genetic transformation system

[0145] 5-1. VIGS system detection was performed using the cloroplastos alterados 1 gene, i.e., GhCLA1 gene, as a marker gene. This gene is involved in the chloroplast development process and encodes 1-deoxyxylulose 5-phosphate synthase (DXS) protein. It is highly conserved in evolution. After silencing the GhCLA1 gene, the cotton plant has an obvious albino phenotype, which is an easily identifiable marker trait. The results are shown in Figure 1 Middle A. Two weeks after VIGS injection, the true leaves of plants in the TRV:GhCLA1 treatment group were almost completely bleached, while the leaves of the control (TRV:00 treatment group) showed no changes ( Figure 1 (B) This indicates that the TRV-mediated VIGS system was successfully established in upland cotton TM-1.

[0146] 5-2. Fluorescence quantitative Real time-PCR detection

[0147] Plant Total RNA Extraction Kit was used to extract total RNA from cotton plant leaves 2 weeks after VIGS infection. Using cotton UBQ7 as the internal reference gene, fluorescence quantitative Real time-PCR was used to detect the expression of the GhCBL3 gene after silencing. The results are shown in Figure 2 Compared with the empty vector (TRV:00) control, in a randomly selected GhCBL3 gene VIGS-infected plant, the expression level of the GhCBL3 gene was significantly decreased, and the silencing effect was obvious.

[0148] The instrument used for fluorescence quantitative PCR was Applied Biosystems StepOne (Applied Biosystems, USA), and the reagent used was SYBR Premix Ex Taq TM Kit (TransGene, Beijing). Reverse transcribed cDNA was used as template, the starting amount was 150 ng, and each treatment was repeated 3 times. The reaction procedure was: denaturation (95°C, 30 s); amplification (95°C, 5 s; 58°C, 15 s; 72°C, 31 s) for 40 cycles; dissolution (95°C, 15 s; 60°C, 1 min; 95°C, 15 s). The primer sequences for fluorescence quantitative Realtime-PCR detection are as follows:

[0149] Primer GhUBQ7-RT-F: 5′-GAAGGCATTCCACCTGACCAAC-3′;

[0150] Primer GhUBQ7-RT-R: 5′-CTTGACCTTCTTCTTCTTGTGCTTG-3′.

[0151] Primer GhCBL3-RT-F: 5′-TACGATCTCAAGCAGCAAGGTT-3′;

[0152] Primer GhCBL3-RT-R: 5′-ATGTCGCAAAACAAGGCTTCTC-3′.

[0153] 6. Cotton Verticillium wilt inoculation and disease resistance identification

[0154] Resistance identification was performed by artificial inoculation of Verticillium dahliae V991 (also referred to herein as Verticillium dahliae V991 or Verticillium wilt strain V991 or V991), and the specific steps were as follows:

[0155] The preserved Verticillium wilt strain V991 was activated on PDA medium. The bacteria were picked and cultured in Czapek's culture medium at 25°C and 200r / min for 3 to 5 days. The pathogen culture medium was filtered through 4 layers of gauze, and the concentration of pathogens was counted using a hemocytometer. The final concentration of pathogens was adjusted to 1.0×10 7 spores / mL, and Tween-20 was added to a final concentration of 0.001% (volume percentage) to obtain the spore solution of Verticillium wilt pathogen V991. The transformed strains obtained after VIGS gene silencing for 2 weeks were inoculated with the spore solution of pathogen V991 by root immersion method. The incidence of Verticillium wilt was investigated and counted 12 days after inoculation, and the disease index was calculated using the 0-4 level method. 30 individual plants were treated for each material. Three biological replicates were set.

[0156] Disease index statistics references: Xu Li, Zhu Longfu, Zhang Xianlong, Research progress on resistance mechanism of cotton to Verticillium wilt. Acta Agron Sin, 2012, 38: 1553–1560; Xu L, Zhu LF, Zhang X L. Research on resistance mechanism of cotton to Verticillium wilt. Acta Agron Sin, 2012, 38: 1553–1560.

[0157] Disease index = [(number of diseased plants at each level × corresponding disease level) / total number of plants surveyed × highest disease level (4)] × 100

[0158] Two weeks after VIGS infection, the silenced plants treated with TRV:GhCBL3 and the control plants with empty vector (TRV:00) were inoculated with Verticillium dahliae strain V991. The incidence of Verticillium wilt 12 days later was as follows: Figure 1 As shown in C. Through three biological replicates and statistical analysis, the results of disease resistance identification at 16d and 21d after inoculation with Verticillium dahliae V991 are shown in Figure 3 As shown. The control plants injected with empty vector (transgenic plants obtained by TRV:00 treatment) had an incidence rate of 50.55 and an average disease index of 34.55 16 days after inoculation, and an incidence rate of 72.05 and an average disease index of 67.22 21 days after inoculation. The plants after GhCBL3 gene silencing (transgenic plants obtained by TRV:GhCBL3 treatment) had an incidence rate of 36.54 and an average disease index of 22.74 16 days after inoculation, and an incidence rate of 49.05 and an average disease index of 39.97 21 days after inoculation.

[0159] The results showed that compared with the control, the incidence and disease index of the plants after GhCBL3 gene silencing were significantly reduced, indicating that the disease resistance of the plants after GhCBL3 gene silencing was enhanced. This indicates that the GhCBL3 gene is involved in the hypersensitive response induced by Verticillium wilt.

[0160] The above experimental results fully prove that the expression level of the GhCBL3 gene is significantly reduced after VIGS infection, and the disease resistance of the plant is enhanced after the GhCBL3 gene is silenced. The experimental results show that inhibiting (downregulating) the expression of the GhCBL3 gene in plants (such as cotton) can significantly improve the disease resistance of the plant (such as improving the resistance to Verticillium wilt in cotton). The GhCBL3 protein of the present invention and its encoding gene GhCBL3 can regulate the disease resistance of the plant (such as Verticillium wilt resistance), and the disease resistance of the target plant can be significantly improved by reducing the content and / or activity of the GhCBL3 protein in the target plant (such as inhibiting, silencing or interfering with the expression of the GhCBL3 gene).

[0161] The present invention has been described in detail above. It will be apparent to those skilled in the art that the present invention may be implemented in a wide range under equivalent parameters, concentrations and conditions without departing from the spirit and scope of the present invention and without the need for unnecessary experimentation. Although the present invention provides specific embodiments, it should be understood that further improvements may be made to the present invention. In short, according to the principles of the present invention, this application intends to include any changes, uses or improvements to the present invention, including changes made by conventional techniques known in the art that depart from the scope disclosed in this application. Applications of some of the basic features may be made within the scope of the following appended claims.

Claims

1. Application for reducing protein content and / or activity, characterized in that, The application is any of the following: A1) Application in improving the resistance of upland cotton to Verticillium wilt; A2) Application in the preparation of products for improving the resistance of upland cotton to Verticillium wilt; A3) Application in breeding upland cotton resistant to Verticillium wilt; A4) Use in the preparation of products for breeding upland cotton resistant to Verticillium wilt; A5) Application in breeding of upland cotton for resistance to Verticillium wilt or improving upland cotton germplasm resources for resistance to Verticillium wilt; A6) Application in the prevention and control of Verticillium wilt disease in upland cotton; The protein is any of the following: B1) a protein whose amino acid sequence is SEQ ID No. 1; B2) A fusion protein with the same function is obtained by connecting a tag to the N-terminus and / or C-terminus of B1).

2. Use of a biomaterial related to the protein according to claim 1, characterized in that: The application is any of the following: D1) Application in improving the resistance of upland cotton to Verticillium wilt; D2) Application in the preparation of products that improve the resistance of upland cotton to Verticillium wilt; D3) Application in breeding upland cotton resistant to Verticillium wilt; D4) Use in the preparation of products for breeding upland cotton resistant to Verticillium wilt; D5) Application in breeding of upland cotton for resistance to Verticillium wilt or improving upland cotton germplasm resources for resistance to Verticillium wilt; D6) Application in the prevention and control of Verticillium wilt disease in upland cotton; The biological material is any one of the following E1) to E7): E1) a nucleic acid molecule that inhibits or reduces the expression of the gene encoding the protein of claim 1; E2) an expression cassette containing the nucleic acid molecule described in E1); E3) a recombinant vector containing the nucleic acid molecule described in E1), or a recombinant vector containing the expression cassette described in E2); E4) a recombinant microorganism containing the nucleic acid molecule described in E1), or a recombinant microorganism containing the expression cassette described in E2), or a recombinant microorganism containing the recombinant vector described in E3); E5) a transgenic plant cell line containing the nucleic acid molecule described in E1), or a transgenic plant cell line containing the expression cassette described in E2), or a transgenic plant cell line containing the recombinant vector described in E3); E6) transgenic plant tissue containing the nucleic acid molecule described in E1), or transgenic plant tissue containing the expression cassette described in E2); E7) A transgenic plant organ containing the nucleic acid molecule described in E1) or a transgenic plant organ containing the expression cassette described in E2).

3. The use according to claim 2, characterized in that: The nucleotide sequence encoding the protein is shown in SEQ ID No.

2.

4. A method for cultivating plants resistant to Verticillium wilt, characterized in that: The method comprises reducing the content and / or activity of the protein in claim 1 in a target plant, thereby obtaining a disease-resistant plant having higher Verticillium wilt resistance than the target plant, wherein the plant is upland cotton.

5. The method according to claim 4, characterized in that The reduction of the content and / or activity of the protein in claim 1 in the target plant is achieved by reducing the expression level of the gene encoding the protein in the target plant.

6. The method according to claim 5, characterized in that The reducing the expression level of the gene encoding the protein in the target plant is to reduce the expression level of the gene encoding the protein in claim 1 in the target plant genome by using gene mutation, gene knockout, gene editing or gene knockdown technology.

7. The method according to claim 6, characterized in that The gene knockdown technology is used to reduce the expression level of the gene encoding the protein described in claim 1 in the genome of the target plant by using a virus-induced gene silencing vector, and the virus-induced gene silencing vector is a recombinant vector constructed by forward integration of the nucleic acid molecule shown in SEQ ID No. 3 into a plasmid vector based on tobacco rattle virus.